RANDOX C-REACTIVE PROTEIN CALIBRATOR

K022682 · Randox Laboratories, Ltd. · JIS · Nov 5, 2002 · Clinical Chemistry

Device Facts

• Record ID: K022682
• Device Name: RANDOX C-REACTIVE PROTEIN CALIBRATOR
• Applicant: Randox Laboratories, Ltd.
• Product Code: JIS · Clinical Chemistry
• Decision Date: Nov 5, 2002
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 862.1150
• Device Class: Class 2

Intended Use

The Randox Laboratories Limited C-Reactive Protein Calibrators are liquid calibrators containing human recombinant CRP in a stabilised protein matrix. They have been developed for use in the calibration of CRP assays. The constituent concentrations of the Randox Laboratories Limited C-Reactive Protein Calibrator are present at 6 levels. The Randox Laboratories Limited C-Reactive Protein Calibrators should only be used by suitably qualified laboratory personnel under appropriate laboratory conditions.

Device Story

Randox C-Reactive Protein Calibrator is a liquid calibrator containing human recombinant CRP in a stabilized protein matrix. It is provided at 6 concentration levels. Used by qualified laboratory personnel in clinical laboratory settings to calibrate CRP assays. The device ensures accurate measurement of CRP levels in patient samples by establishing a reference curve for the assay. It is a prescription-use in vitro diagnostic device.

Clinical Evidence

No clinical data provided; bench testing only.

Technological Characteristics

Liquid calibrator containing human recombinant CRP in a stabilized protein matrix. Provided at 6 concentration levels. In vitro diagnostic device.

Indications for Use

Indicated for use as a calibrator for CRP assays. Intended for use by qualified laboratory personnel in a clinical laboratory setting.

Regulatory Classification

Identification

A calibrator is a device intended for medical purposes for use in a test system to establish points of reference that are used in the determination of values in the measurement of substances in human specimens. (See also § 862.2 in this part.)

Special Controls

*Classification.* Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image shows a logo with the words "MAN SERVICES USA" at the top and "DEPARTM" at the bottom. In the center of the logo is a stylized graphic that resembles a bird or a series of curved lines. The logo is black and white and appears to be a seal or emblem.

Food and Drug Administration 2098 Gaither Road Rockville MD 20850

Dr. Pauline Armstrong Regulatory Affairs Randox Laboratories Limited 55 Diamond Road Crumlin, County Antrim, United Kingdom BT29 4QY

5 2002 NOV

k022682 Re:

Trade/Device Name: C-Reactive Protein Calibrator Regulation Number: 21 CFR 862.1150 Regulation Name: Calibrator Regulatory Class: Class II Product Code: JIS Dated: August 5, 2002 Received: August 12, 2002

Dear Dr. Armstrong:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

{1}------------------------------------------------

## Page 2 -

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and ' additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at [phone]. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at [phone]. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers International and Consumer Assistance at its toll-free number [phone] or [phone] or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html".

Sincerely yours.

Steven Sutman

Steven I. Gutman, M.D., M.B.A. Director Division of Clinical Laboratory Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Page 1 of 1

K022682

| 510(k) Number (if known) | NOT KNOWN |
|--------------------------|-------------------------------|
| Device Name | C-REACTIVE PROTEIN CALIBRATOR |

## Indications For Use :

The Randox Laboratories Limited C-Reactive Protein Calibrators are liquid calibrators containing human recombinant CRP in a stabilised protein matrix. They have been developed for use in the calibration of CRP assays. The constituent concentrations of the Randox Laboratories Limited C-Reactive Protein Calibrator are present at 6 levels.

The Randox Laboratories Limited C-Reactive Protein Calibrators should only be used by suitably qualified laboratory personnel under appropriate laboratory conditions.

Concurrence of CDRH, Office of Device Evaluation (ODE)

**Prescription Use**
(Per 21 CFR 801.109) √

OR

Over-The-Counter Use (Optional format 1-2-96)

(Liaison Sign-Off)

of Clinical Laboratory Devices 51 Ujk) Number -